Press Releases
October 6, 2016
SBP Receives DSMB Approval to Start 4th Patient Cohort in SBP-101 Dose Escalation Phase 1 Study
October 3, 2016
SBP Announces Effectiveness of its Registration Statement on Form S-1
Company Uplists to OTCQB Venture Market and Secures DTC Eligibility
August 15, 2016
SBP Announces Completion of 2nd Patient Cohort, Starts Recruitment of 3rd Cohort Patients
August 11, 2016
SBP Files Form 10-Q for 2nd Quarter 2016 & Provides Business Update
June 28, 2016
Sun BioPharma, Inc. Raises $2.0 Million Through Private Placement Transaction
May 23, 2016
Sun BioPharma Completes 1st Patient Cohort & Starts Recruitment of 2nd Cohort Patients in Dose Escalation Phase 1 Study
May 16, 2016
Sun BioPharma Provides Business Update and Reports Financial Results for Q1 2016
March 8, 2016
Sun BioPharma Reports Financial Results for Year Ended 12/31/15
March 3, 2016
Dr. Dalvir S. Gill Appointed to Sun BioPharma Board of Directors
January 6, 2016